Literature DB >> 20679347

Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.

Daniel Canals1, Russell W Jenkins, Patrick Roddy, María José Hernández-Corbacho, Lina M Obeid, Yusuf A Hannun.   

Abstract

ERM proteins are regulated by phosphorylation of the most C-terminal threonine residue, switching them from an activated to an inactivated form. However, little is known about the control of this regulation. Previous work in our group demonstrated that secretion of acid sphingomyelinase acts upstream of ERM dephosphorylation, suggesting the involvement of sphingomyelin (SM) hydrolysis in ERM regulation. To define the role of specific lipids, we employed recombinant bacterial sphingomyelinase (bSMase) as a direct probe of SM metabolism at the plasma membrane. bSMase induced a rapid dose- and time-dependent decrease in ERM dephosphorylation. ERM dephosphorylation was driven by ceramide generation and not by sphingomyelin depletion, as shown using recombinant sphingomyelinase D. The generation of ceramide at the plasma membrane was sufficient for ERM regulation, and no intracellular SM hydrolysis was required, as was visualized using Venus-tagged lysenin probe, which specifically binds SM. Interestingly, hydrolysis of plasma membrane bSMase-induced ceramide using bacterial ceramidase caused ERM hyperphosphorylation and formation of cell surface protrusions. The effects of plasma membrane ceramide hydrolysis were due to sphingosine 1-phosphate formation, as ERM phosphorylation was blocked by an inhibitor of sphingosine kinase and induced by sphingosine 1-phosphate. Taken together, these results demonstrate a new regulatory mechanism of ERM phosphorylation by sphingolipids with opposing actions of ceramide and sphingosine 1-phosphate. The approach also defines a tool kit to probe sphingolipid signaling at the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679347      PMCID: PMC2952249          DOI: 10.1074/jbc.M110.141028

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells.

Authors:  Flavia A Wald; Andrea S Oriolo; Anastasia Mashukova; Nevis L Fregien; Amber H Langshaw; Pedro J I Salas
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

2.  Androgen induction of prostate cancer cell invasion is mediated by ezrin.

Authors:  Yin-Choy Chuan; See-Tong Pang; Angel Cedazo-Minguez; Gunnar Norstedt; Ake Pousette; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2006-07-26       Impact factor: 5.157

3.  Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus.

Authors:  Yansong Li; Tatsuhiro Harada; Yuang-Taung Juang; Vasileios C Kyttaris; Ying Wang; Michael Zidanic; Kenneth Tung; George C Tsokos
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 4.  Acid ceramidase inhibition: a novel target for cancer therapy.

Authors:  Xiang Liu; Saeed Elojeimy; Lorianne S Turner; Ayman E M Mahdy; Youssef H Zeidan; Alicja Bielawska; Jacek Bielawski; Jian-Yun Dong; Ahmed M El-Zawahry; Gui-wen Guo; Yusuf A Hannun; David H Holman; Semyon Rubinchik; Zdzislaw Szulc; Thomas E Keane; Mahvash Tavassoli; James S Norris
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Innate immunity, macrophage activation, and atherosclerosis.

Authors:  Zhong-qun Yan; Göran K Hansson
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

Review 6.  Principles of bioactive lipid signalling: lessons from sphingolipids.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

7.  Ceramide-induced transbilayer (flip-flop) lipid movement in membranes.

Authors:  F-Xabier Contreras; Ana-Victoria Villar; Alicia Alonso; Félix M Goñi
Journal:  Methods Mol Biol       Date:  2009

8.  Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42.

Authors:  Soren Prag; Maddy Parsons; Melanie D Keppler; Simon M Ameer-Beg; Paul Barber; James Hunt; Andrew J Beavil; Rosy Calvert; Monique Arpin; Borivoj Vojnovic; Tony Ng
Journal:  Mol Biol Cell       Date:  2007-05-30       Impact factor: 4.138

9.  Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway.

Authors:  Youssef H Zeidan; Russell W Jenkins; Yusuf A Hannun
Journal:  J Cell Biol       Date:  2008-04-21       Impact factor: 10.539

10.  Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.

Authors:  Vijay R Gupta; Hetal K Patel; Sean S Kostolansky; Roberto A Ballivian; Joseph Eichberg; Steven R Blanke
Journal:  PLoS Pathog       Date:  2008-05-23       Impact factor: 6.823

View more
  41 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase.

Authors:  Daniel Canals; Patrick Roddy; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2012-02-06       Impact factor: 5.157

3.  Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.

Authors:  K Alexa Orr Gandy; Mohamad Adada; Daniel Canals; Brittany Carroll; Patrick Roddy; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2013-04-29       Impact factor: 5.191

Review 4.  Visualizing bioactive ceramides.

Authors:  Daniel Canals; Silvia Salamone; Yusuf A Hannun
Journal:  Chem Phys Lipids       Date:  2018-09-25       Impact factor: 3.329

Review 5.  Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.

Authors:  Daniel Canals; David M Perry; Russell W Jenkins; Yusuf A Hannun
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

6.  How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.

Authors:  Daniel Serrano; Rachel L Manthe; Eden Paul; Rishi Chadha; Silvia Muro
Journal:  Biomacromolecules       Date:  2016-09-15       Impact factor: 6.988

7.  Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.

Authors:  Djanybek M Adyshev; Nurgul K Moldobaeva; Venkateswaran R Elangovan; Joe G N Garcia; Steven M Dudek
Journal:  Cell Signal       Date:  2011-08-12       Impact factor: 4.315

8.  Inhibition of glycosphingolipid biosynthesis induces cytokinesis failure.

Authors:  G E Atilla-Gokcumen; A V Bedigian; S Sasse; U S Eggert
Journal:  J Am Chem Soc       Date:  2011-06-14       Impact factor: 15.419

Review 9.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

10.  Sphingosine 1-phosphate activation of ERM contributes to vascular calcification.

Authors:  Thomas G Morris; Samantha J Borland; Christopher J Clarke; Claire Wilson; Yusuf A Hannun; Vasken Ohanian; Ann E Canfield; Jacqueline Ohanian
Journal:  J Lipid Res       Date:  2017-11-22       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.